NYSE: NVO
Novo Nordisk A S Stock Ownership - Who owns Novo Nordisk (Ozempic)?

Insider buying vs selling

Have Novo Nordisk A S insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NVO insiders and whales buy or sell their stock.

NVO Shareholders

What type of owners hold Novo Nordisk A S stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Xxecin0.00%129,894$5.04MInstitution
Dodcox0.00%20,397$791.40kInstitution
Dodge Cox0.00%20,397$791.40kInstitution
Loomis Sayles Co L P0.00%18,594$721.45kInstitution
Loosay0.00%18,594$721.45kInstitution
Frares0.00%13,041$505.99kInstitution
Franklin Templeton Inc0.00%13,041$505.99kInstitution
Franklin Resources Inc0.00%13,041$505.99kInstitution
Prictr0.00%11,705$454.15kInstitution
Price T Rowe Associates Inc0.00%11,704$454.12kInstitution

1 of 3

NVO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVO0.01%0.00%
VRTX0.10%1.52%Net SellingNet Selling
REGN0.09%39.28%Net SellingNet Buying
MRNA0.08%24.05%Net BuyingNet Buying
ARGX0.05%0.00%

Novo Nordisk (Ozempic) Stock Ownership FAQ

Who owns Novo Nordisk (Ozempic)?

Novo Nordisk (Ozempic) (NYSE: NVO) is owned by 0.01% institutional shareholders, 0.00% Novo Nordisk (Ozempic) insiders, and 99.99% retail investors. Xxecin is the largest individual Novo Nordisk (Ozempic) shareholder, owning 129,894.00 shares representing 0.00% of the company. Xxecin's Novo Nordisk (Ozempic) shares are currently valued at $5.04M.

If you're new to stock investing, here's how to buy Novo Nordisk (Ozempic) stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.